Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Synthesis and Evaluation of Benzoquinolinone Derivatives as SARS-CoV 3CL Protease Inhibitors

  • Published : 2010.01.20
Download PDF
⟨ Previous Next ⟩

Abstract

For the discovery of new antivirals against Severe Acute Respiratory Syndrome-coronavirus (SARS-CoV), we prepared and evaluated several benzoquinoline compounds as its 3C-like protease (3CLpro) inhibitors. Based on the computer modeling study that each of the two rigid benzoquinolinone and N-phenoltetrazole moieties of the compound 1 is bound to the S1 and S2 sites, respectively, of the SARS protease by forming H-bonds and hydrophobic interactions, we designed and synthesized alkylated benzoquinolines at both the sites of the hydroxyl groups. We found that the compound 2a showed five times higher inhibiting activity against the 3CLpro compared to the compound 1.

Keywords

References

  1. Ksiazek, T. G.; Erdman, D.; Goldsmith, C. S.; Zaki, S. R.; Peret, T.; Emery, S.; Tong, S.; Urbani, C.; Comer, J. A.; Lim, W.; Rollin, P. E.; Dowell, S. F.; Ling, A. E.; Humphrey, C. D.; Shieh, W. J.; Guarner, J.; Paddock, C. D.; Rota, P.; Fields, B.; DeRisi, J.; Yang, J. Y.; Cox, N.; Hughes, J. M. N. Eng. J. Med. 2003, 348, 1953-1966. https://doi.org/10.1056/NEJMoa030781
  2. Liang, P. H. Curr. Top Med. Chem. 2006, 6, 361-376. https://doi.org/10.2174/156802606776287090
  3. Kuo, C. J.; Liu, H. G.; Lo, Y. K.; Seong, C. M.; Lee, K. I.; Jung, Y. S.; Liang, P. H. FEBS Lett. 2009, 583, 549-555. https://doi.org/10.1016/j.febslet.2008.12.059
  4. De Clercq, E. Expert Rev. Anti Infect. Ther. 2006, 4, 291-302. https://doi.org/10.1586/14787210.4.2.291
  5. Zhai, S.; Liu, W.; Yan, B. Recent Patents Anti-Infect Drug Disc. 2007, 2, 1-10.
  6. Melnick, J. L. Enterovirus: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses In Virology, 3rd ed.; Lippincott-Raven: Philadephia, U.S.A. 1996.
  7. Krausslich, H. G.; Wimmer, E. Annu. Rev. Biochem. 1998, 57, 701-754. https://doi.org/10.1146/annurev.bi.57.070188.003413
  8. Kuo C. J.; Shie, J. J.; Fang, J. M.; Yen, G. R.; Hsu, J. T. A.; Tseng, S. N.; Chang, S. C.; Lee, C. Y.; Shih, S. R.; Liang, P. H. Bioorg. Med. Chem. 2008, 16, 7388-7398. https://doi.org/10.1016/j.bmc.2008.06.015
  9. Kuo, C. J.; Chi, Y. H.; Hsu, J. T. A.; Liang, P. H. Biochem. Biophys. Res. Commun. 2004, 318, 862-867. https://doi.org/10.1016/j.bbrc.2004.04.098
  10. Yang, H.; Yang, M.; Ding, Y.; Liu, Y.; Lou, Z.; Zhou, Z.; Sun, L.; Mo, L.; Ye, S.; Pang, H.; Gao, G. F.; Anard, K.; Bartlam, M.; Hilgenfeld, R.; Rao, Z. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 13190-13195. https://doi.org/10.1073/pnas.1835675100
  11. Matthews, D. A.; Dragovich, P. S.; Webber, S. E.; Fuhrman, S. A.; Patick, A. K.; Zalman, L. S.; Hendrickson, T. F.; Love, R. A.; Prins, T. J.; Marakovits, J. T.; Zhou, R.; Tikhe, J.; Ford, C. E.; Meador, J. W.; Ferre, R. A.; Brown, E. L.; Binford, S. L.; Brothers, M. A.; Delisle, D. M.; Worland, S. T. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 11000-11007. https://doi.org/10.1073/pnas.96.20.11000

Cited by

  1. Lopinavir; A Potent Drug against Coronavirus Infection: Insight from Molecular Docking Study vol.12, pp.4, 2017, https://doi.org/10.5812/archcid.13823
  2. ChemInform Abstract: Synthesis and Evaluation of Benzoquinolinone Derivatives as SARS-CoV 3CL Protease Inhibitors. vol.41, pp.22, 2010, https://doi.org/10.1002/chin.201022130
  3. Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease vol.20, pp.12, 2010, https://doi.org/10.1016/j.bmcl.2010.04.118
  4. Synthesis and Biological Evaluation of Quinolinone Compounds as SARS CoV 3CLpro Inhibitors vol.31, pp.9, 2010, https://doi.org/10.1002/cjoc.201300392
  5. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy vol.59, pp.14, 2010, https://doi.org/10.1021/acs.jmedchem.5b01461
  6. Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen vol.4, pp.3, 2010, https://doi.org/10.1021/acsptsci.0c00216
  7. Perspectives on SARS-CoV-2 Main Protease Inhibitors vol.64, pp.23, 2010, https://doi.org/10.1021/acs.jmedchem.1c00409